Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Dechra Pharmaceuticals PLC Director's Dealing 2014

Sep 15, 2014

4797_dirs_2014-09-15_26677633-43e8-44da-b0a0-7c2a5ba30e1b.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7212R

Dechra Pharmaceuticals PLC

15 September 2014

15 September 2014

Dechra Pharmaceuticals PLC

(the Company)

Director / PDMR Shareholding

The Company announces that, today, the following Directors/PDMRs have been granted nil cost options over ordinary shares of 1 pence each in the Company in connection with the Dechra Long Term Incentive Plan 2008 (the Plan):

Name of individual Director/PDMR Type of award Number of shares subject to award
Ian Page Director Option 115,334
Anne-Francoise Nesmes Director Option 60,747
Tony Griffin Director Option 29,937
Zoe Goulding PDMR Option 9,174

The vesting of all the above awards is subject to the achievement of performance targets.  In respect of these grants the performance conditions will be determined by reference to the Company's Earnings per Share (EPS) and its Total Shareholder Return (TSR) relative to constituent companies of the FTSE 250 index (excluding investment trusts) over a three year performance period.  Both the EPS and TSR elements will be subject to an additional Return on Capital Employed (ROCE) performance measure.  If the ROCE performance condition is not met, then the LTIP options will lapse in full.

For further information, please contact:

Zoe Goulding, Company Secretary            

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSQKPDDQBKDACD